{"schema_version":"secwatch.filing_event.v1","accession":"0000939930-22-000057","form_type":"8-K","ticker":"PYYX","cik":"0000939930","company_name":"PYXUS INTERNATIONAL, INC.","filed_at":"2022-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.109225+00:00","generated_at":"2026-06-22T00:29:50.808014+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Pyxus Q2 sales up 29% to $508.3M; net loss narrows to $1.5M; maintains FY guidance","bullets":["Sales rose 28.9% to $508.3M, driven by 17.5% higher leaf volume and 13.3% higher avg price per kilo.","Operating income improved to $27.1M from $5.5M; adjusted EBITDA $42.2M, up 63% YoY.","Net loss attributable to Pyxus improved by $8.2M to $1.5M for Q2 fiscal 2023.","FY2023 guidance maintained: sales $1.75B-$1.95B, adjusted EBITDA $130M-$160M.","Inventories of $890.1M, 90%+ processed tobacco committed; La Nina and inflation impacts cited."],"urls":{"canonical":"https://secwatch.observer/filing/0000939930-22-000057","json":"https://secwatch.observer/filing/0000939930-22-000057.json","markdown":"https://secwatch.observer/filing/0000939930-22-000057.md","text":"https://secwatch.observer/filing/0000939930-22-000057.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/939930/000093993022000057/0000939930-22-000057-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/939930/000093993022000057/pyx-20221110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T00:29:50.808014+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d624dd99a68b4286e2519d659349ef3d7a97ac05","claim":"PYXUS INTERNATIONAL, INC. reported fiscal quarter ended September 30, 2022 results: revenue $508.3 million, net income $1.5 million. Guidance reaffirmed.","evidence_excerpt":"quarter ended September 30, 2022. Highlights (comparisons are to the relevant prior-year period): • Sales and other operating revenues increased $114.1 million, or 28.9%, to $508.3 million for the three months ended September 30, 2022. • Operating margin increased $21.6 million to $27.1 million for the three months ended September 30, 2022. • Net loss attributable","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/939930/000093993022000057/0000939930-22-000057-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal quarter ended September 30, 2022"},{"label":"Revenue","value":"$508.3 million"},{"label":"Net income","value":"$1.5 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}